Tris Pharma, Inc.
Clinical trials sponsored by Tris Pharma, Inc., explained in plain language.
-
New pain drug shows promise in tummy tuck recovery
Symptom relief CompletedThis study tested a new pain medication called cebranopadol in 279 people who had a tummy tuck (abdominoplasty). The goal was to see if it safely reduces moderate to severe pain after surgery compared to a placebo. Participants received either the drug or a dummy pill, and pain l…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:58 UTC
-
New painkiller cebranopadol tested for Post-Surgery relief
Symptom relief CompletedThis study tested a new pain medicine called cebranopadol in 240 adults who had bunion surgery. The goal was to see if it safely reduces moderate to severe pain better than a placebo or another painkiller. Participants rated their pain and satisfaction, and researchers tracked ho…
Phase: PHASE3 • Sponsor: Tris Pharma, Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:34 UTC
-
New painkiller tested for abuse risk – could it be safer than oxycodone?
Knowledge-focused CompletedThis study tested a new painkiller called cebranopadol to see how much people like it compared to oxycodone and a placebo when snorted. It involved 48 healthy adults who had used opioids for fun before. The goal was to measure abuse potential, which helps understand if the drug m…
Phase: PHASE1 • Sponsor: Tris Pharma, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC